In continuation of last week’s essay, Type 2 is the most common type of ED in men under 45. It is also the only type that has absolutely no mainstream ...
UVA is conducting a clinical trial exploring the potential of low-intensity shockwave therapy to address erectile dysfunction by promoting new blood vessel growth and tissue repair. The federal Food ...
AMSTERDAM — A noninvasive EEG-based test may help predict the risk of sexual dysfunction for patients considering treatment with antidepressants, a new study showed. The Loudness Dependence of ...
LONDON, April 23 (Reuters) - British drug development firm Vectura Group Plc said on Monday a phase two clinical study on its inhaled erectile dysfunction product had been successful. Vectura said in ...
According to the National Institutes of Health (NIH), erectile dysfunction (ED) affects about 30 million men in the United States. While it’s not unusual to have difficulty maintaining an erection ...
UNDATED (WKRC) - A dietary supplement was recalled after testing showed that it contains an erectile dysfunction drug. Testing revealed that the supplement Wonder Pill had an undeclared ingredient, ...
LONDON, April 23 (Reuters) - British drug development firm Vectura Group Plc said on Monday a phase two clinical study on its inhaled erectile dysfunction (ED) product had been successful. "It is ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results